• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/10/21 10:52:44 AM ET
    $EVR
    Investment Managers
    Finance
    Get the next $EVR alert in real time by email
    SC 13G/A 1 tv0816-evercoreincclassa.htm SCHEDULE 13G/A evercoreincclassa

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 7)*

    Name of issuer:  Evercore Inc. Class A

    Title of Class of Securities:  Common Stock

    CUSIP Number:  29977A105

    Date of Event Which Requires Filing of this Statement: December 31, 2020

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  29977A105

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    27,295

    7.  SOLE DISPOSITIVE POWER

    3,382,237

    8.  SHARED DISPOSITIVE POWER

    60,195

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    3,442,432

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    8.47%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    Evercore Inc. Class A

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    55 East 52nd Street
    38th Floor
    New York, New York 10055

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    29977A105

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

    3,442,432

      (b) Percent of Class:

    8.47%

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  0

    (ii)  shared power to vote or direct to vote:  27,295

    (iii)  sole power to dispose of or to direct the disposition of:  3,382,237

    (iv)  shared power to dispose or to direct the disposition of:  60,195

    Comments:

     

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    Not applicable

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    See Attached Appendix A

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 8, 2021

    By /s/ Christine M. Buchanan
    Name: Christine M. Buchanan
    Title:  Principal

     

     

    Appendix A

    Subsidiary:

    Vanguard Asset Management, Limited

    Vanguard Fiduciary Trust Company

    Vanguard Global Advisors, LLC

    Vanguard Group (Ireland) Limited

    Vanguard Investments Australia Ltd

    Vanguard Investments Canada Inc.

    Vanguard Investments Hong Kong Limited

    Vanguard Investments UK, Limited

    *Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G

     

    Get the next $EVR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EVR

    DatePrice TargetRatingAnalyst
    1/26/2026$435.00Buy
    BofA Securities
    12/11/2025$340.00Neutral
    UBS
    12/8/2025$373.00Overweight → Equal-Weight
    Morgan Stanley
    10/9/2025$400.00Buy
    Deutsche Bank
    10/3/2025$358.00Market Perform
    BMO Capital Markets
    7/14/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    6/23/2025$312.00Equal-Weight → Overweight
    Morgan Stanley
    4/8/2025$230.00Mkt Perform → Mkt Outperform
    Citizens JMP
    More analyst ratings

    $EVR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Varney Christine A

    3 - Evercore Inc. (0001360901) (Issuer)

    3/20/26 4:31:48 PM ET
    $EVR
    Investment Managers
    Finance

    Director Williamson Sarah K bought $580,860 worth of Shares of Class A common stock (2,000 units at $290.43), increasing direct ownership by 18% to 13,345 units (SEC Form 4)

    4 - Evercore Inc. (0001360901) (Issuer)

    3/10/26 5:01:56 PM ET
    $EVR
    Investment Managers
    Finance

    CEO/Chairman Weinberg John S was granted 31,528 units of Shares of Class A common stock, increasing direct ownership by 5% to 636,890 units (SEC Form 4)

    4 - Evercore Inc. (0001360901) (Issuer)

    2/23/26 4:30:32 PM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    David Ke Joins Evercore as Senior Managing Director in the Equity Capital Markets Group

    Evercore announced today that David Ke has joined the firm as a senior managing director in the equity capital markets group, focused on biotechnology. He will be based in New York. "We are excited to welcome David to Evercore," said Naveen Nataraj, co-head of U.S. investment banking. "Biotechnology remains one of the most dynamic sectors in equity capital markets, and David's experience and deep investor relationships enhance our capabilities as we continue to support innovative companies as they access capital." "David brings a strong track record and deep biotechnology expertise to Evercore," said Kristy Grippi, head of equity capital markets at Evercore. "His experience will further

    3/12/26 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    Evercore Wealth Management Promotes Sean Brady to Partner

    Evercore Wealth Management today announced the promotion of Sean Brady to partner. Mr. Brady is a wealth & fiduciary advisor at Evercore Wealth Management and its affiliate, Evercore Trust Company. "Sean is an experienced and thoughtful advisor," said Chris Zander, CEO of Evercore Wealth Management and Evercore Trust Company. "He is a strong contributor to our firm, able to manage complex planning challenges while always putting our clients first and working well within our unique team structure." Mr. Brady works with senior executives, private equity principals and families, delivering integrated strategic wealth planning and fiduciary services. He joined Evercore in 2024 from Clarfeld

    3/4/26 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    Ben Carpenter Joins Evercore as Senior Managing Director in the Healthcare Investment Banking Group

    Evercore announced today that Ben Carpenter has joined the firm as a senior managing director in the healthcare investment banking group, where he will focus on the biopharma sector. He will be based in San Francisco. "We are pleased to welcome Ben to Evercore," said Naveen Nataraj, co-head of U.S. investment banking. "His extensive healthcare experience will further strengthen our franchise as we continue to invest in and expand our healthcare advisory platform." "We are excited to have Ben join the firm," said Francois Maisonrouge, chairman of Evercore's global healthcare group. "Biopharma is one of the most dynamic areas in global healthcare. Continuing to deepen our presence in this

    3/2/26 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Williamson Sarah K bought $580,860 worth of Shares of Class A common stock (2,000 units at $290.43), increasing direct ownership by 18% to 13,345 units (SEC Form 4)

    4 - Evercore Inc. (0001360901) (Issuer)

    3/10/26 5:01:56 PM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities initiated coverage on Evercore with a new price target

    BofA Securities initiated coverage of Evercore with a rating of Buy and set a new price target of $435.00

    1/26/26 10:01:23 AM ET
    $EVR
    Investment Managers
    Finance

    UBS resumed coverage on Evercore with a new price target

    UBS resumed coverage of Evercore with a rating of Neutral and set a new price target of $340.00

    12/11/25 9:08:53 AM ET
    $EVR
    Investment Managers
    Finance

    Evercore downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Evercore from Overweight to Equal-Weight and set a new price target of $373.00

    12/8/25 8:21:30 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    SEC Filings

    View All

    SEC Form 10-K filed by Evercore Inc.

    10-K - Evercore Inc. (0001360901) (Filer)

    2/20/26 4:51:14 PM ET
    $EVR
    Investment Managers
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Evercore Inc.

    SCHEDULE 13G/A - Evercore Inc. (0001360901) (Subject)

    2/10/26 11:21:52 AM ET
    $EVR
    Investment Managers
    Finance

    SEC Form 8-K filed by Evercore Inc.

    8-K - Evercore Inc. (0001360901) (Filer)

    2/4/26 5:00:33 PM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Evercore Inc.

    SC 13G/A - Evercore Inc. (0001360901) (Subject)

    10/4/24 2:32:45 PM ET
    $EVR
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by Evercore Inc. (Amendment)

    SC 13G/A - Evercore Inc. (0001360901) (Subject)

    2/13/24 5:04:33 PM ET
    $EVR
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by Evercore Inc. (Amendment)

    SC 13G/A - Evercore Inc. (0001360901) (Subject)

    7/10/23 10:41:25 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    Financials

    Live finance-specific insights

    View All

    Evercore Reports Record Fourth Quarter and Full Year 2025 Revenues; Quarterly Dividend of $0.84 Per Share

    Evercore Inc. (NYSE:EVR):   Fourth Quarter Results   Full Year Results   U.S. GAAP   Adjusted   U.S. GAAP   Adjusted   Q4 2025 Q4 2024   Q4 2025 Q4 2024     2025     2024       2025     2024   Net Revenues ($ mm) $ 1,288.3   $ 975.3     $ 1,298.1   $ 980.5     $ 3,855.8   $ 2,979.6     $ 3,884.0   $ 3,002.6   Operating Income

    2/4/26 6:45:00 AM ET
    $EVR
    Investment Managers
    Finance

    Evercore to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 4, 2026

    Evercore (NYSE:EVR) will release its fourth quarter and full year 2025 financial results on Wednesday, February 4, 2026 at 6:45 a.m. Eastern Time. Evercore will host a related conference call, accessible via telephone and webcast, beginning at 8:00 a.m. Eastern Time that same day. Evercore's Chairman and Chief Executive Officer, John S. Weinberg, and Chief Financial Officer, Tim LaLonde, will review the Firm's fourth quarter and full year 2025 financial results. Following the review, there will be a question and answer session. This conference call is expected to last approximately one hour. Investors and analysts may participate in the live conference call by dialing (800) 245-3047 (to

    1/21/26 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    Evercore Reports Third Quarter 2025 Results; Quarterly Dividend of $0.84 Per Share

    Evercore Inc. (NYSE:EVR):   Third Quarter Results   Year to Date Results   U.S. GAAP   Adjusted   U.S. GAAP   Adjusted   Q3 2025 Q3 2024   Q3 2025 Q3 2024   YTD 2025 YTD 2024   YTD 2025 YTD 2024 Net Revenues ($ mm) $ 1,038.9   $ 734.2     $ 1,047.1   $ 739.5     $ 2,567.5   $ 2,004.3     $ 2,585.8   $ 2,022.1   Operating Income ($ mm) $ 216.2   $

    10/29/25 6:45:00 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    Leadership Updates

    Live Leadership Updates

    View All

    David Ke Joins Evercore as Senior Managing Director in the Equity Capital Markets Group

    Evercore announced today that David Ke has joined the firm as a senior managing director in the equity capital markets group, focused on biotechnology. He will be based in New York. "We are excited to welcome David to Evercore," said Naveen Nataraj, co-head of U.S. investment banking. "Biotechnology remains one of the most dynamic sectors in equity capital markets, and David's experience and deep investor relationships enhance our capabilities as we continue to support innovative companies as they access capital." "David brings a strong track record and deep biotechnology expertise to Evercore," said Kristy Grippi, head of equity capital markets at Evercore. "His experience will further

    3/12/26 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    Ben Carpenter Joins Evercore as Senior Managing Director in the Healthcare Investment Banking Group

    Evercore announced today that Ben Carpenter has joined the firm as a senior managing director in the healthcare investment banking group, where he will focus on the biopharma sector. He will be based in San Francisco. "We are pleased to welcome Ben to Evercore," said Naveen Nataraj, co-head of U.S. investment banking. "His extensive healthcare experience will further strengthen our franchise as we continue to invest in and expand our healthcare advisory platform." "We are excited to have Ben join the firm," said Francois Maisonrouge, chairman of Evercore's global healthcare group. "Biopharma is one of the most dynamic areas in global healthcare. Continuing to deepen our presence in this

    3/2/26 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    Ben Hart Joins Evercore as Senior Managing Director and Head of Asia Private Capital Advisory

    Evercore (NYSE:EVR) announced today that Ben Hart has joined the firm as a senior managing director and head of its Asia Private Capital Advisory (PCA) division. Based in Singapore, Mr. Hart will oversee Evercore PCA's activities across the Asia-Pacific region and work closely with the global PCA team to further expand the firm's secondaries advisory and broader private markets capabilities in the region. "We are thrilled to welcome Ben to Evercore," said Nigel Dawn, global head of Evercore's PCA division. "Ben has built an exceptional reputation and deep relationships across Asia's private markets ecosystem. His extensive experience in capital formation and distribution across APAC will

    2/23/26 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance